recurrence is a major problem which affects 40% of Breast cancer patients . Bcl2 is an antiapoptotic protein which is implicated in many cases of cancer development and cancer resistance to therapy.
Aim of study : investigate the role of Bcl2 in recurrence in Breast cancer patients
